In order to study the relationship between COVID-19 and heart disease, the American College of Cardiology (ACC) announced recently that it will start using two data registries to monitor how the virus affects patients who suffer a variety of major cardiac events or medical procedures.
Hospitals already contributing to the National Cardiovascular Data Registry (NCDR) Chest Pain-MI and CathPCI registries will be able to add to the world’s growing knowledge on the impact of the virus on cardiovascular disease, according to the ACC. New hospitals can also join the registries and begin sharing any applicable patient data related to the ongoing pandemic.
“Registries will play a key role in understanding how this virus influences the care and outcomes for individuals with heart disease, both now and in the future,” NCDR Management Board Chair and Chief Scientific Advisor Frederick Masoudi, MD, said in a statement.
Early on, it was clear that heart disease patients are disproportionately affected by the coronavirus and experience higher rates of mortality and morbidity. Also, patients without a history of heart disease have a worse prognosis when they develop cardiac complications caused by the virus.
By adding COVID-19 data elements to existing registries, ACC and participating clinicians, hospitals and health systems can monitor the impact of the virus on patients experiencing a heart attack or undergoing cath or PCI procedures.
Long-term data will also allow for future research on COVID-19, including its impacts on specific racial, ethnic and gender groups, and identify where gaps and/or disparities in care exist.
“We are learning every day how COVID-19 impacts our patients,” says ACC President Athena Poppas, MD. “By adapting our registries to answer pressing scientific questions and knowledge gaps, we can ensure that our cardiovascular care team has validated data and updated tools to provide the highest quality care, particularly during these uncertain times.